-
Multi-stakeholder platform to improve clinical trials
Multi-stakeholder platform to improve clinical trials
-
Multi-stakeholder platform to improve clinical trials
Multi-stakeholder platform to improve clinical trials
EMA, the Heads of Medicines Agencies and the European Commission are launching a public consultation on a multi-stakeholder platform aimed to improve clinical trials in the EU
-
HMPC Chair re-elected
HMPC Chair re-elected
-
HMPC Chair re-elected
HMPC Chair re-elected
EMA’s Committee on Herbal Medicinal Products (HMPC) has re-elected Dr Emiel van Galen from the Medicines Evaluation Board (CBG-MEB) as its Chair
-
New role for EMA during public health emergencies
New role for EMA during public health emergencies
-
New role for EMA during public health emergencies
New role for EMA during public health emergencies
Additional responsibilities for monitoring and mitigation shortages of critical medical devices during public health emergencies now apply
-
CTIS now mandatory for new trial applications
CTIS now mandatory for new trial applications
-
CTIS now mandatory for new trial applications
CTIS now mandatory for new trial applications
From 31 January 2023, all initial clinical trial applications in the European Union must be submitted via the Clinical Trials Information System (CTIS)
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal